• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.65% Nasdaq Down1.89%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    31.70 Down 0.58(1.80%) Jan 27, 4:00PM EST
    |After Hours : 32.28 Up 0.58 (1.83%) Jan 27, 4:52PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 14   28   30   37  
    Cost of Revenue -   -   -   -  
    Gross Profit 14   28   30   37  
    Operating Expenses
    Research Development16,953  13,799  11,668  7,925  
    Selling General and Administrative8,056  7,952  6,320  4,276  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (24,995) (21,723) (17,958) (12,164)
    Income from Continuing Operations
    Total Other Income/Expenses Net209  228  130  115  
    Earnings Before Interest And Taxes(24,786)(21,495)(17,828)(12,049)
    Interest Expense -   -   -   -  
    Income Before Tax(24,786)(21,495)(17,828)(12,049)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(24,786)(21,495)(17,828)(12,049)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (24,786) (21,495) (17,828) (12,049)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (24,786) (21,495) (17,828) (12,049)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.